Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Change in Receivables (2018 - 2026)

Health Catalyst filings provide 9 years of Change in Receivables readings, the most recent being $591000.0 for Q1 2026.

  • On a quarterly basis, Change in Receivables fell 90.26% to $591000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$3.7 million, a 163.26% decrease, with the full-year FY2025 number at $1.8 million, up 142.26% from a year prior.
  • Change in Receivables hit $591000.0 in Q1 2026 for Health Catalyst, up from -$900000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $15.4 million in Q1 2023 to a low of -$9.5 million in Q2 2023.
  • Median Change in Receivables over the past 5 years was $591000.0 (2026), compared with a mean of $646705.9.
  • Biggest five-year swings in Change in Receivables: surged 2327.66% in 2022 and later tumbled 395.85% in 2023.
  • Health Catalyst's Change in Receivables stood at -$1.6 million in 2022, then surged by 976.7% to $13.9 million in 2023, then tumbled by 85.47% to $2.0 million in 2024, then tumbled by 144.49% to -$900000.0 in 2025, then soared by 165.67% to $591000.0 in 2026.
  • The last three reported values for Change in Receivables were $591000.0 (Q1 2026), -$900000.0 (Q4 2025), and -$7.9 million (Q3 2025) per Business Quant data.